Come up with a name for your new list and we'll add to it:
KemPharm raised a round of funding on May 30, 2013. Investors include
DeWaay Investment Partners.
KemPharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (NCEs) to treat serious medical conditions through its proprietary and broadly applicable Liga…